2007PEC Conf CaptBatts Meals Meds Market Share

Information about 2007PEC Conf CaptBatts Meals Meds Market Share

Published on February 20, 2008

Author: Mee12

Source: authorstream.com

Content

Meals, Medications and Market Share:  Meals, Medications and Market Share Understanding the Tenuous Relationship of Physicians and Pharmaceutical Representatives Travis C. Batts, Capt, USAF, MC Wilford Hall Medical Center The Case:  The Case A physician enters his busy suburban practice on the outskirts of Metro city. He sees an average of 30-50 patients daily but finds his job fulfilling and enjoyable. He effortlessly glides from room to room believing each patient has a unique and dynamic problem, that only he can accurately address. The Case:  The Case As he leaves the exam room, the tranquility of his daily routine is abruptly disrupted……………. MERCK PFIZER ELI LILLY SCHERING-PLOUGH BRISTOL-MYERS GSK DOES THIS REALLY OCCUR???????? OVERVIEW:  OVERVIEW HISTORY REPRESENTATIVE TRAINING INDUSTRY STRUCTURE Barriers to Success Product Driven vs. People Driven ROLES CONCLUSION HISTORY:  HISTORY When did it all start? Late 19th century Eli Lilly and Squibb only national companies (manufacture >> development) 1895 diphtheria and tetanus antitoxin produced initially France/Germany later in New York 1906 Food and Drug Act (The Wiley Act) 1911 U.S. v. Johnson 1912 Shirley Amendment WWI/WWII increased need for products but goods produced abroad 13 companies formed to increase production of dried plasma and penicillin Post war expansion HISTORY:  HISTORY Pharmaceutical Representatives ………. Courtesy of Sylvian Cazalet TRAINING:  TRAINING Undergraduate School Science vs. Business Foreign Language, Math, Accounting Postgraduate Education MBA MPH PhD MD TRAINING:  TRAINING ONCE HIRED, LET THE LEARNING BEGIN What is your strength? Science or Business What are your assets? Familiar with territory Relationships Knowing the lay of the land Community Connections “Stickablity” TRAINING- Knowing the Drug:  TRAINING- Knowing the Drug Pharmacology Pharmacodynamics Drugs on the Body Pharmacokinetics Body on the Drugs Time of abs Duration of action Distribution Method of excretion Physiology in the context of the pharmacology Disease States Symptoms Complications Costs TIME CONSUMING Training- Knowing How to Sell:  Training- Knowing How to Sell Learn your territory The Doctors The Staff The Patients (patient population) Marketing Travel for training Shadowing Doctors Representatives Industry Structure:  Industry Structure National Level Regional Level (Director) Regulate training and testing Dictate % market share change needed Predict rate of change in accordance to national mandates District level (Manager) Facilitates all of the above Give Quarterly Data/Updates to Reps Regulates Territory Territory (Pharm Rep) Industry Structure:  Industry Structure Industry Structure:  Industry Structure How it works Representative learns the drug New vs. Old (patent length) Representative learns the district/territory The Doctors, Staff, Patient Population Computer Based Prescribing Info Queries (1-5) 1- few scripts of your drug (what he writes, why he writes it, and how can I make him change?) 5- Heavy hitter, enjoy having him on your team (How do you keep him writing? Can he write more?) 2-4- Marketing/Needs/Visits Industry Structure:  Industry Structure Think about it like pie…….. THE MARKET = THE PIE You must/can SHARE the pie = market share The more slices of pie you have……… Barriers to Success:  Barriers to Success Patent Life (20 years but decreased with R&D) Source: Pharmaceutical Research and Manufacturers of America Industry Profile 2002. Barriers to Success:  Barriers to Success Growing Generic Drug Market Health Policy Prescriptions, Vol. 1, No. 9, Pacific Research Institute (Sept. 2002). Barriers to Success:  Barriers to Success Shift in advertising American Medical News December 25, 2006 Barriers to Success:  Barriers to Success Competition External vs. Internal New vs. Old Urban vs. Rural vs. Suburban Barriers to Success:  Barriers to Success Laws Regulations/Reforms Pharmaceutical, Research and Manufacturers of America (PhRMA Code) General Interactions CME Entertainment Consultants Educational/Health care practice related items No Free Lunch Association Guidelines AMA, ACP, ACCME Roles of the “Actors”:  Roles of the “Actors” Goals Controlling agenda Influencing outcomes Representative Vendor Educator Donor Physician Purchaser Information Seeker Recipient Adapted from: Dramaturgal Study of Meeting… (Goffman’s Model) Somerset et al, BMJ 2001 Roles of the “Actors”:  Roles of the “Actors” Goffman Model Expanded Short conversations dictate large amounts of power/influence Effective encounters occur only in the context of a performance Adapted from: Dramaturgal Study of Meeting… (Goffman’s Model) Somerset et al, BMJ 2001 The Performance:  The Performance Scene 1 - Recognition of status Scene 2 – Assessing Ability/Understanding Scene 3 – Cost/Benefit Analysis Scene 4 – Turning Point (+, -) Scene 5 - Reinforce status/stature Scene 6 - Closure Adapted from: Dramaturgal Study of Meeting… (Goffman’s Model) Somerset et al, BMJ 2001 Conclusion:  Conclusion Pharmaceutical industry has long history closely tied to medical economics Understanding training that representative undergo may help in understanding their role Keep in mind, primary goal is market share growth Evaluate your performances, making sure your integrity is not compromised in the interaction Questions??????:  Questions?????? ROCK CHALK JAYHAWK! References:  References Somerset et al. BMJ. Vol 323. DEC 2001 Backer E. Journal of Family Practice. SEP 2000 Health Policy Prescription. Vol 1, No 9, (SEP 2002) Studdert et al. NEJM. Vol 351; 18 AMA New. DEC 25, 2006 IMAGES WERE OBTAINED FROM GOOGLE IMAGE WITH FOLLOWING KEY WORDS: pie, jayhawk, Shakespeare, salesman, united states, pharmacologic graph

Related presentations


Other presentations created by Mee12

08 Dog and Cat Nutrition
16. 11. 2007
0 views

08 Dog and Cat Nutrition

miguel angel bustamante
01. 10. 2007
0 views

miguel angel bustamante

Athens 2004
02. 10. 2007
0 views

Athens 2004

hauer1
27. 09. 2007
0 views

hauer1

aws
06. 11. 2007
0 views

aws

Chapters 9 10
26. 11. 2007
0 views

Chapters 9 10

ContinuousIntegration final
28. 11. 2007
0 views

ContinuousIntegration final

N A V I G T O R S VBB 2007
30. 11. 2007
0 views

N A V I G T O R S VBB 2007

Fruit Insects
01. 12. 2007
0 views

Fruit Insects

raghavachari
04. 12. 2007
0 views

raghavachari

Test Anxiety 1
06. 12. 2007
0 views

Test Anxiety 1

ProvidentialHistory
31. 10. 2007
0 views

ProvidentialHistory

chap08 og
01. 11. 2007
0 views

chap08 og

handout 184637
05. 11. 2007
0 views

handout 184637

2004 harm present
05. 11. 2007
0 views

2004 harm present

E DESC AK PACOM POL CONF ver31
13. 11. 2007
0 views

E DESC AK PACOM POL CONF ver31

bedeutung innovation
15. 11. 2007
0 views

bedeutung innovation

Parity01 grames slides
23. 11. 2007
0 views

Parity01 grames slides

GA Conf07Lomas
13. 12. 2007
0 views

GA Conf07Lomas

CooperativeLearning
17. 12. 2007
0 views

CooperativeLearning

Friendship 1
23. 12. 2007
0 views

Friendship 1

plant lifecycles
28. 12. 2007
0 views

plant lifecycles

Millay
28. 12. 2007
0 views

Millay

alterman pki 05 13 01
01. 01. 2008
0 views

alterman pki 05 13 01

RMA 2005
02. 01. 2008
0 views

RMA 2005

OH
04. 01. 2008
0 views

OH

pp Bioeconomy Polansky Dec2007
04. 01. 2008
0 views

pp Bioeconomy Polansky Dec2007

nazca lines
07. 01. 2008
0 views

nazca lines

4330IBS
30. 10. 2007
0 views

4330IBS

Wk4 Mon
04. 01. 2008
0 views

Wk4 Mon

lh1
21. 11. 2007
0 views

lh1

econ and mgnt of privatization
20. 11. 2007
0 views

econ and mgnt of privatization

jre imps2005
06. 11. 2007
0 views

jre imps2005

EE541 451 class29
28. 11. 2007
0 views

EE541 451 class29

Aquatic Equipment
08. 11. 2007
0 views

Aquatic Equipment

WomensEmploymentJan2 001
24. 02. 2008
0 views

WomensEmploymentJan2 001

1025 QM05 Nardi
29. 10. 2007
0 views

1025 QM05 Nardi

wendybear
24. 12. 2007
0 views

wendybear

Martinac
14. 03. 2008
0 views

Martinac

DynaMed
25. 10. 2007
0 views

DynaMed

IntStu
27. 03. 2008
0 views

IntStu

Country Risk Sep07
13. 04. 2008
0 views

Country Risk Sep07

Eco 336 Constitutional Limits on
17. 12. 2007
0 views

Eco 336 Constitutional Limits on

2003 lecture crypto1
31. 12. 2007
0 views

2003 lecture crypto1

robo lectures
14. 11. 2007
0 views

robo lectures

Ders1
29. 12. 2007
0 views

Ders1

REDLOBSTER
07. 12. 2007
0 views

REDLOBSTER

WarmUps WHII
25. 12. 2007
0 views

WarmUps WHII

pres riccardo
30. 10. 2007
0 views

pres riccardo

Chapt3overhead
12. 11. 2007
0 views

Chapt3overhead

SHFA280301
28. 11. 2007
0 views

SHFA280301

IfA jan03v1
15. 11. 2007
0 views

IfA jan03v1